Log In
Print this Print this

Tasigna, nilotinib

Also known as: formerly AMN107

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionBCR-ABL tyrosine kinase inhibitor
Molecular Target BCR-ABL tyrosine kinase
Mechanism of ActionBCR-ABL tyrosine kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today